FMP

FMP

Morgan Stanley Sets New Price Target for Fractyl Health Inc (GUTS) on NASDAQ

  • Morgan Stanley has set a new price target for NASDAQ:GUTS at $2, indicating a potential increase of about 245% from its current trading price.
  • The stock has experienced a significant decrease of 68.04%, trading at $0.58, down from its previous levels.
  • GUTS has shown volatility with a yearly high of $3.03 and a low of $0.56, alongside a trading volume of 87.51 million shares, reflecting active investor interest.

GUTS, trading on the NASDAQ, is currently under the spotlight following Morgan Stanley's price target announcement. On January 29, 2026, Morgan Stanley set a price target of $2 for GUTS, while the stock was trading at approximately $0.58. This target suggests a potential increase of about 245% from its current trading price.

The stock is currently priced at $0.58, reflecting a significant decrease of 68.04% from its previous levels. This drop represents a change of -$1.24. Today, GUTS has fluctuated between a low of $0.56 and a high of $0.68, indicating volatility in its trading pattern.

Over the past year, GUTS reached a high of $3.03 and a low of $0.56. This wide range highlights the stock's volatility and potential for significant price movements. The market capitalization of GUTS is approximately $42.23 million, which provides insight into the company's size and market presence.

The trading volume for GUTS is 87.51 million shares, suggesting active investor interest. This level of trading activity can influence the stock's price movements and reflects the market's response to recent developments, such as Morgan Stanley's price target announcement.